Randomized Double-Blind Placebo-Controlled Clinical Trial to Assess the Efficacy of Mycophenolate Mofetil in Subclinical Interstitial Lung Disease Associated with Systemic Sclerosis: a Feasibility Study
评估吗替麦考酚酯治疗与系统性硬化症相关的亚临床间质性肺病疗效的随机双盲安慰剂对照临床试验:一项可行性研究
基本信息
- 批准号:463257
- 负责人:
- 金额:$ 25.25万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-03-01 至 2025-12-01
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Scleroderma (or systemic sclerosis) is a rare but life-threatening disease in which the immune system attacks its own tissues, leading to excessive scarring (fibrosis) of the skin and internal organs. Scleroderma affects over 10,000 individuals in Canada
硬皮病(或系统性硬化症)是一种罕见但危及生命的疾病,免疫系统攻击自己的组织,导致皮肤和内脏过度结疤(纤维化)。在加拿大,硬皮病影响着1万多人
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hoa Sabrina A其他文献
Hoa Sabrina A的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hoa Sabrina A', 18)}}的其他基金
Immunosuppressive treatment for interstitial lung disease in systemic sclerosis: effectiveness in mild and late clinical subtypes
系统性硬化症间质性肺疾病的免疫抑制治疗:对轻度和晚期临床亚型的有效性
- 批准号:
367130 - 财政年份:2016
- 资助金额:
$ 25.25万 - 项目类别:
Studentship Programs
相似海外基金
Persistent micro- and nanoplastics as triggers for interstitial lung disease
持久性微塑料和纳米塑料是间质性肺病的诱因
- 批准号:
MR/Y012682/1 - 财政年份:2024
- 资助金额:
$ 25.25万 - 项目类别:
Research Grant
Clinical Practice of Lung Volumetric Evaluation by Computed Tomography in Patients with Interstitial Lung Disease
间质性肺病患者计算机断层扫描肺容量评估的临床实践
- 批准号:
23K16580 - 财政年份:2023
- 资助金额:
$ 25.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
- 批准号:
10634881 - 财政年份:2023
- 资助金额:
$ 25.25万 - 项目类别:
Development of protein biomarkers for rheumatoid arthritis associated interstitial lung disease
类风湿性关节炎相关间质性肺病蛋白质生物标志物的开发
- 批准号:
23K06879 - 财政年份:2023
- 资助金额:
$ 25.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes
计算机断层扫描和间质性肺疾病结果的肺血管修剪
- 批准号:
10661883 - 财政年份:2023
- 资助金额:
$ 25.25万 - 项目类别:
Dyspnea during sexual activity in patients with fibrotic interstitial lung disease
纤维化间质性肺病患者性活动时呼吸困难
- 批准号:
480727 - 财政年份:2023
- 资助金额:
$ 25.25万 - 项目类别:
Distinguishing Phenotypes of Pulmonary Hypertension in Patients with Connective Tissue Disease-related Interstitial Lung Disease
结缔组织病相关间质性肺病患者肺动脉高压表型的区分
- 批准号:
10748841 - 财政年份:2023
- 资助金额:
$ 25.25万 - 项目类别:
Deep Immunophenotyping of the Immune Response in Interstitial Lung Disease: Developing a Cellular and Protein Biomarker Discovery Pipeline for Idiopathic Pulmonary Fibrosis
间质性肺疾病免疫反应的深度免疫表型分析:开发特发性肺纤维化的细胞和蛋白质生物标志物发现管道
- 批准号:
474502 - 财政年份:2022
- 资助金额:
$ 25.25万 - 项目类别:
Studentship Programs
Novel Therapeutics for Interstitial Lung Disease: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
间质性肺疾病的新疗法:修饰的水溶性 Caveolin-1 支架结构域肽,具有改进的药物开发特性
- 批准号:
10544228 - 财政年份:2022
- 资助金额:
$ 25.25万 - 项目类别:
Vasculopathy and Systemic Sclerosis-Associated Interstitial Lung Disease
血管病变和系统性硬化症相关间质性肺病
- 批准号:
10680544 - 财政年份:2022
- 资助金额:
$ 25.25万 - 项目类别: